AllianceBernstein’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-393,782
| Closed | -$29.6M | – | 3323 |
|
|
2022
Q2 | $29.6M | Sell |
393,782
-1,641,267
| -81% | -$124M | 0.01% | 724 |
|
|
2022
Q1 | $54.6M | Buy |
2,035,049
+25,858
| +1% | +$694K | 0.02% | 573 |
|
|
2021
Q4 | $95.8M | Buy |
2,009,191
+756,418
| +60% | +$36.1M | 0.03% | 451 |
|
|
2021
Q3 | $83.2M | Sell |
1,252,773
-185,633
| -13% | -$12.3M | 0.03% | 476 |
|
|
2021
Q2 | $112M | Buy |
1,438,406
+382,520
| +36% | +$29.8M | 0.05% | 395 |
|
|
2021
Q1 | $99.9M | Buy |
1,055,886
+110,475
| +12% | +$10.4M | 0.04% | 402 |
|
|
2020
Q4 | $115M | Sell |
945,411
-133,685
| -12% | -$16.3M | 0.05% | 331 |
|
|
2020
Q3 | $94.3M | Sell |
1,079,096
-63,575
| -6% | -$5.55M | 0.05% | 341 |
|
|
2020
Q2 | $73.8M | Buy |
1,142,671
+537,113
| +89% | +$34.7M | 0.04% | 413 |
|
|
2020
Q1 | $27M | Buy |
605,558
+55,901
| +10% | +$2.5M | 0.02% | 595 |
|
|
2019
Q4 | $34.2M | Buy |
549,657
+101,029
| +23% | +$6.29M | 0.02% | 646 |
|
|
2019
Q3 | $16.9M | Buy |
448,628
+49,192
| +12% | +$1.85M | 0.01% | 854 |
|
|
2019
Q2 | $16.3M | Buy |
+399,436
| New | +$16.3M | 0.01% | 875 |
|